TCM LTD.

TCM Ltd has announced the launch of its Poultry Feed product line as part of its expansion strategy for the Feed division. The new operation is established at a leased facility in Palakkad, Kerala, with a built-up area of 10,760 Sq Ft. This expansion aims to add approximately 1500 Tonnes per month capacity exclusively for poultry feed. The company has invested ₹2.50 Crore, comprising ₹0.50 Crore for machinery and tools and ₹1.50 Crore for working capital, financed through internal accruals. The rationale behind this move is to sustain long-term growth, meet evolving market demands, and enhance customer satisfaction. Initial capacity utilization for the new poultry feed line is expected to be less than 20% in the first six months, with the full capacity targeted by September 2026.

TCM Ltd has announced its Annual General Meeting (AGM) scheduled for Friday, 25th September 2026. The company is enclosing the Notice of the AGM along with the Annual Report for the Financial Year 2025-2026, as per Regulation 34. The annual report highlights the company's product range, including advanced diagnostic solutions like Fluorescreen FIA-101 POCT Immuno Assay, Fluorecare MF-T1000 POCT Platform, Tesmi-i50 Neo, Portable Immune Analyzer WIZ-TCM IA-101, and Fully Automated Urinalysis Hybrid. These products are designed for rapid, accurate testing in point-of-care and laboratory settings. The filing also lists the company's directors, managing director, company secretary, CFO, statutory auditors, secretarial auditors, internal auditors, registered office details, share transfer agents, and bankers.

TCM Ltd has announced that the Register of Members and Share Transfer Book will be closed from September 19, 2026, to September 25, 2026. The company has fixed September 18, 2026, as the record date to identify shareholders eligible to vote at the 82nd Annual General Meeting (AGM). The AGM is scheduled to be held on September 25, 2026, for the financial year ended March 31, 2026. This action is in compliance with SEBI (LODR) Regulations, 2015, and the Companies Act, 2013.

TCM Ltd's Board of Directors met on August 13, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also approved the notice for the 82nd Annual General Meeting, scheduled for September 25, 2026. Additionally, the Directors' Report, Corporate Governance Report, and Secretarial Audit Report for FY 2025-2026 were approved. The closure of the Share Transfer Register and the retirement of directors by rotation were also sanctioned. Recommendations were made for the re-appointment of Independent Directors Mr. Gopalakrishnan Mahesh and Mr. Jose Jacob for a second term.

TCM Ltd has announced a Board of Directors meeting scheduled for August 13, 2026. The primary agenda items include the consideration and approval of the Consolidated and Standalone Unaudited Financial Results for the quarter ended June 30, 2026. Additionally, the board will review and approve the Directors Report, Corporate Governance Report, and Secretarial Auditors Report for FY 2025-2026. The meeting will also focus on fixing the date, time, and agenda for the 82nd Annual General Meeting. The trading window will reopen 48 hours after the financial results are declared.

The Board of Directors of TCM Ltd approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, in its meeting held on May 26, 2026. The board also declared that the auditor's report on the audited financial results has an unmodified opinion. Additionally, M/s Jomy Saimon and Associates were appointed as the Internal Auditors for FY 2026-27.

TCM Ltd has announced that a meeting of its Board of Directors is scheduled for May 26, 2026, to consider and approve the Consolidated and Standalone Audited Financial Statements of the Company for the quarter and year ended March 31, 2026. The trading window, previously closed on March 27, 2026, will re-open 48 hours after the declaration of the financial results.

TCM Ltd announced the cancellation of a work order for a Solar PV installation project from CIAL Infrastructures Limited, a subsidiary of Cochin International Airport Limited. The project, valued at ₹7,92,07,425 (excluding GST), involved the design, installation, testing, and commissioning of ground-mounted solar PV installations totaling 7.5 MWp. CIAL Infrastructures Ltd terminated the order due to circumstances beyond its control, as communicated on April 28, 2026. TCM Ltd has been requested to submit details of work executed for final settlement. The cancellation means the ₹7.92 crore turnover will not be reflected in TCM Ltd's billings.

TCM Ltd has received declarations under Regulation 31(4) of SEBI (SAST) Regulations, 2011 from its promoters, Mr. Joseph Varghese, Mr. George Varghese, and Ms. Rani Jose, for the financial year ended March 31, 2026. The declarations confirm that the promoters, along with persons acting in concert, have not made any encumbrance, directly or indirectly, during the financial year 2025-2026. These declarations are in compliance with SEBI circular SEBI/HO/CFD/DCR-3/P/CIR/2022/27 dated 07.03.2022.

The Board of Directors of TCM Ltd. has approved a Term Loan of Rs. 1.37 Crore from Indian Bank, Vytilla Branch, Emakulam. The loan, which carries a variable interest rate of 9.60%, will be used for working capital needs and will be repaid in 174 EMIs over a period of residual 174 months, with a 6-month holiday period for interest servicing. The loan will be secured by mortgaging Door nos. 8/96-2 & 3 of the company's Hi-Lite property in Maradu, Emakulam.